Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06410001 · ClinicalTrials.gov registry record · Phase 1
CE-STAND: Cervical Epidural STimulation After Neurologic Damage
A Phase 1 study of Spinal Cord Injury, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06410001 is a Phase 1 study of Spinal Cord Injury that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 36 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06410001, a Phase 1 study of Spinal Cord Injury, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.
Conditions Studied
Interventions
- DEVICE Epidural Spinal Cord Stimulation System
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2030-07-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06410001
The ClinicalTrials.gov registry entry for NCT06410001 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (58% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Epidural Spinal Cord Stimulation System is the first listed.
NCT06410001 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06410001 about?
NCT06410001 is a clinical study titled "CE-STAND: Cervical Epidural STimulation After Neurologic Damage". CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.
What is the current status of trial NCT06410001?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2026-03-01. Estimated completion is 2030-07-30.
What conditions does trial NCT06410001 study?
This clinical trial studies the following conditions: Spinal Cord Injury.
What interventions are being tested in trial NCT06410001?
The interventions under investigation include: Epidural Spinal Cord Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT06410001?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06410001 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury
RECRUITING · Phase 1
-
Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury
RECRUITING · Phase 1
-
Platelet-Rich Plasma Therapy for Shoulder Pain in Persons With Spinal Cord Injury
COMPLETED · Phase 1
-
A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries
COMPLETED · Phase 1
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.